SUPRIYA logo

Supriya Lifescience LTD

SUPRIYA·NSE·
834.35 +31.20 (+3.88%)
Market Cap6466.48 Cr
PE Ratio32.12
Volume5,31,783
Day High - Low845.80 - 800.00
52W High-Low1085.00 - 545.50
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
17.45%
Strong
P/E
32.12x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day800.00
845.80
52W545.50
1085
DocStoX take

Supported by risk (8.5) and quality (7.8), but held back by valuation (2.0). Risk looks strong at 8.5, but that is offset by valuation at 2.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Excellent
ROE 17.4%
Valuation
Expensive
P/E 32.1×
Growth
Steady
Revenue +16.2% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Firm
54% of 52-week range

At a glance

Market Cap
₹6,466 Cr
52W High / Low
₹1085 / ₹546
Dividend Yield
0.13%
Promoter Holding
68.30%
EPS (TTM)
₹25.98
Book Value
₹148.92

Key highlights

  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Healthy net margin (25%)
  • Valuation is weak (2.0/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

SUPRIYA LIFESCIENCE LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.